Aclaris Therapeutics Quote - ACRS

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

2.75

Bid

2.74

Offer

2.75

Volume

365,470

2.71 Day's Range 2.90

0.80 52 Week Range 5.17

Market Cap

196.435M

Previous Close

2.77

Open

2.74

Last Trade

2.75

Last Trade Time

05:52:51

Financial Volume

US$ 1,026,355

VWAP

2.8083

Average Volume (3m)

2,447,063

Shares Outstanding

71,430,942

Dividend Yield

PE Ratio

-2.23

Earnings Per Share (EPS)

-1.24

Revenue

31.25M

Net Profit

-88.48M

Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United States. It focuses on developing novel drug candidates for immuno-inflammatory diseases. The company operates in two segments: therapeutics and contract research. The majority of its revenue comes from... Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United States. It focuses on developing novel drug candidates for immuno-inflammatory diseases. The company operates in two segments: therapeutics and contract research. The majority of its revenue comes from the contract research segment, which provides laboratory services. Its drug candidates under development are Zunsemetinib, which is an Oral MK2 Inhibitor; ATI-2138 is an ITJ Inhibitor; and ATI-1777. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.aclaristx.com

Headquarters

Wilmington, Delaware, USA

Founded

Aclaris Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ACRS. The last closing price for Aclaris Therapeutics was US$2.77. Over the last year, Aclaris Therapeutics shares have traded in a share price range of US$ 0.80 to US$ 5.17.

Aclaris Therapeutics currently has 71,430,942 shares in issue. The market capitalisation of Aclaris Therapeutics is US$197.86 million. Aclaris Therapeutics has a price to earnings ratio (PE ratio) of -2.23.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.455	-14.1965678627	3.205	3.35	2.71	1061484	3.10186597	CS
4	-1.53	-35.7476635514	4.28	4.44	2.71	1124011	3.62654345	CS
12	1.57	133.050847458	1.18	5.17	1.12	2447063	3.57598151	CS
26	1.59	137.068965517	1.16	5.17	1.1	1502771	2.98727564	CS
52	1.7584	177.329568374	0.9916	5.17	0.8	1404738	2.14632542	CS
156	-11.1	-80.1444043321	13.85	18.9583	0.5902	1166185	4.69271344	CS
260	0.98	55.3672316384	1.77	30.375	0.5902	1044407	7.52766066	CS

ACRS - Frequently Asked Questions (FAQ)

What is the current Aclaris Therapeutics share price?

The current share price of Aclaris Therapeutics is US$ 2.75

How many Aclaris Therapeutics shares are in issue?

Aclaris Therapeutics has 71,430,942 shares in issue

What is the market cap of Aclaris Therapeutics?

The market capitalisation of Aclaris Therapeutics is USD 197.86M

What is the 1 year trading range for Aclaris Therapeutics share price?

Aclaris Therapeutics has traded in the range of US$ 0.80 to US$ 5.17 during the past year

What is the PE ratio of Aclaris Therapeutics?

The price to earnings ratio of Aclaris Therapeutics is -2.23

What is the cash to sales ratio of Aclaris Therapeutics?

The cash to sales ratio of Aclaris Therapeutics is 6.31

What is the reporting currency for Aclaris Therapeutics?

Aclaris Therapeutics reports financial results in USD

What is the latest annual turnover for Aclaris Therapeutics?

The latest annual turnover of Aclaris Therapeutics is USD 31.25M

What is the latest annual profit for Aclaris Therapeutics?

The latest annual profit of Aclaris Therapeutics is USD -88.48M

What is the registered address of Aclaris Therapeutics?

The registered address for Aclaris Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Aclaris Therapeutics website address?

The website address for Aclaris Therapeutics is www.aclaristx.com

Which industry sector does Aclaris Therapeutics operate in?

Aclaris Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Symbol	Price	Vol.
MYSZMy Size Inc	US$ 4.38 (224.44%)	113.48M
EDBLEdible Garden AG Inc	US$ 0.296 (103.58%)	270.87M
NVNINVNI Group Ltd	US$ 5.2943 (98.29%)	36.64M
TPICTPI Composites Inc	US$ 2.03 (66.39%)	11.11M
HSDTHelius Medical Technologies Inc	US$ 0.7702 (60.46%)	111.64M
CYNCYNGN Inc	US$ 0.4287 (-73.37%)	21.64M
MTEMMolecular Templates Inc	US$ 0.145 (-58.57%)	6.73M
PRFXPainReform Ltd	US$ 4.82 (-56.81%)	2.29M
GALTGalectin Therapeutics Inc	US$ 0.901 (-54.95%)	7.69M
FNGRFingerMotion Inc	US$ 1.1701 (-41.50%)	2.82M
APTOAptose Biosciences Inc	US$ 0.251501 (47.77%)	289.95M
EDBLEdible Garden AG Inc	US$ 0.296 (103.58%)	270.87M
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0.5961 (4.58%)	226.72M
RGTIRigetti Computing Inc	US$ 9.5188 (27.43%)	168.34M
NVDANVIDIA Corporation	US$ 133.90 (2.46%)	156.63M

Symbol

Price

Vol.